Title : Oral etoposide.

Pub. Date : 1988 Nov

PMID : 3069425






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Etoposide, a semisynthetic derivative of podophyllotoxin, has been commercially available for intravenous use for a number of years, and has been used as part of first-line combination chemotherapy programs for small cell lung cancer (SCLC). Etoposide SCLC1 Homo sapiens
2 Etoposide for oral use has become commercially available and is approved for use in the treatment of SCLC. Etoposide SCLC1 Homo sapiens
3 Although no clinical trials comparing intravenous and oral etoposide in SCLC have been reported, several pharmacokinetic studies have been described. Etoposide SCLC1 Homo sapiens
4 Oral etoposide has been demonstrated to be effective in the treatment of SCLC. Etoposide SCLC1 Homo sapiens